Sentence examples for tumour up from inspiring English sources

PET imaging studies indicated major radioactive localisation in the chest cavity for both ligands, with approximately 1%ID/g uptake in the tumour at 120 min. Metabolite studies showed that the original radiotracers remained unchanged 65%to80%0% in the tumour up to 120 min. The lead ligands showed promising in vitro and in vivo characteristics.

In addition, the main consequence of increasing the stem cell renewal probability, ps, from 1% assumed throughout is only a slight increase in the degree of branching of the tumour, up to percentages as high as 50%.

Depending on the size of the selection, the number of positions can range from one or two positions (for organs such as the heart, the brain or a tumour) up to tens of positions for total-body scanning.

The Wilms Tumour Surveillance Working Group 2005 have produced a guideline recommending screening of children with conditions with a greater than 5% risk of Wilms tumour up to the age of 5 or 7 years (depending on the condition).

Using specific peptide substrates, there was an increase of 54% in the proteolytic activity of caspase-1, 84% of caspase-8, 98% of caspase-3 151% to caspase-6 and 177% of caspase-9, in the gastrocnemius muscle of animals bearing the MAC16 tumour (up to 25% weight loss), in relation to muscle from animals bearing the MAC13 tumour (1 5% weight loss).

Administration of Zn2+ to animals receiving AT increased the levels of Zn2+ in plasma, gastrocnemius muscle and tumour up to the levels found in PBS controls, consistent with the ability of Zn2+ to attenuate the action of AT on weight loss and tumour volume.

To evaluate the tumour up-take of PS-ODNs delivered by cationic liposome (DOTAP : DOPE).

Although the specific tumour fluorescence signals became weaker over the time, it was easily possible to detect tumours up to 72 h after i.v. probe injection (Figure  4b).

The majority of asymptomatic renal tumours (up to 80%) are detected incidentally at ultrasound.

Bronchial carcinoids now account for 25% of all carcinoid tumours (up from 11.5%, Table 2).

Furthermore, the poor outcome of patients harbouring tumours with AGM was observed in both tumours subgroups, tumours up to 50% and tumours with >50% of tumour cell content.